Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV

Journal of the International AIDS Society

Volumn 12, Issue 1, 2009, Pages

  Tabarsi, Payam ^a   Saber Tehrani, Ali S ^a   Baghaei, Parvaneh ^a   Padyab, Mojgan ^a   Mansouri, Davood ^a   Amiri, Majid ^a   Masjedi, Mohammad Reza ^a   Altice, Frederick L ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AZITHROMYCIN; COTRIMOXAZOLE; EFAVIRENZ; LAMIVUDINE; NELFINAVIR; RIFABUTIN; RIFAMPICIN; ZIDOVUDINE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CEREBRAL TOXOPLASMOSIS; CLINICAL OUTCOME; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS RETINITIS; DIRECTLY OBSERVED THERAPY; DRUG TREATMENT FAILURE; EARLY INTERVENTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIXED INFECTION; MORBIDITY; MORTALITY; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN MANIFESTATION; SURVIVAL RATE; TOXIC HEPATITIS; TUBERCULOSIS; VIRUS TRANSMISSION;

EID: 84904737592     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-12-14     Document Type: Article

References (17)

1. Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniac AL: Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002, 16(1):75-83.
2. McIlleron H, Meintjes G, Burman WJ, Maartens G: Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis 2007, 196(Suppl 1):S63-75.
3. Onyebujoh PC, Ribeiro I, Whalen CC: Treatment options for HIV-associated tuberculosis. J Infect Dis 2007, 196(Suppl 1):S35-45. Review
4. CDC/USPHS/IDSA: Guidelines for the treatment of opportunistic infections among HIV-infected adults and adolescents. MMWR 2004, 53:1-112.
5. Murdoch DM, Venter WD, Van Rie A, Feldman C: Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 2007, 4:9.
6. World Health Organization: TB/HIV – a clinical manual. Geneva; WHO; 2004.
7. AIDS Clinical Trials Group: Table of grading severity of adult adverse experiences. US Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, MD, Bethesda; 1996.
8. French MA, Price P, Stone SF: Immune restoration disease after antiretroviral therapy. AIDS 2004, 18(12):1615-27.
9. Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R, et al.: Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J Gastroenterol Hepatol 2008, 23(2):192-202.
10. Manabe YC, Campbell JD, Sydnor E, Moore RD: Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007, 46(4):456-62.
11. Serra FC, Hadad D, Orofino RL, Marinho F, Lourenco C, Morgado M, Rolla V: Immune reconstitution syndrome in patients treated for HIV and tuberculosis in Rio de Janeiro. Braz J Infect Dis 2007, 11(5):462-5.
12. Sheran M: The nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in the treatment of HIV. HIV Clin Trials 2005, 6(3):158-68.
13. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Vibhagool A: Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand. J Infect 2006, 52(3):188-94.
14. Maher D, Harries A, Getahun H: Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and pro- grammes; implications for policies. Trop Med Int Health 2005, 10(8):734-42.
15. McNabb JJ, Nicolau DP, Stoner JA, Ross J: Patterns of adherence to antiretroviral medications: the value of electronic monitoring. AIDS 2003, 17(12):1763-7.
16. Liddicoat RV, Zheng H, Internicola J, Werner BG, Kazianis A, Golan Y, Rubinstein EP, Freedberg KA, Walensky RP: Implementing a routine, voluntary HIV testing program in a Massachusetts county prison. J Urban Health 2006, 83(6):1127-31.
17. Hammett TM: HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health 2006, 96(6):974-978.